Literature DB >> 14765352

Health-related quality of life of patients with HIV disease: impact of hepatitis C coinfection.

Catherine A Fleming1, Demian Christiansen, David Nunes, Timothy Heeren, David Thornton, C Robert Horsburgh, Margaret James Koziel, Camilla Graham, Donald E Craven.   

Abstract

Health-related quality of life (HRQOL) is diminished in patients infected with both hepatitis C virus (HCV) and human immunodeficiency virus (HIV), but the effect of HIV/HCV coinfection on HRQOL is unknown. We compared the HRQOL of urban HIV/HCV coinfected patients with that of patients infected with either HCV or HIV alone. We then compared the 3 groups with a US population sample, adjusting for demographic characteristics. HRQOL for the group of HIV/HCV coinfected patients was statistically similar to that of HRQOL in patients with either HCV or HIV alone, but the 3 groups had a significantly decreased HRQOL than did the adjusted US population. Using multivariate techniques, we determined that age, unemployment, injection drug use, and depression were associated with impaired HRQOL. These findings underscore the importance of a multidisciplinary approach to the treatment of these patient populations.

Entities:  

Mesh:

Year:  2004        PMID: 14765352     DOI: 10.1086/381263

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  25 in total

Review 1.  Viral hepatitis in HIV infection.

Authors:  Margaret James Koziel; Marion G Peters
Journal:  N Engl J Med       Date:  2007-04-05       Impact factor: 91.245

2.  HIV-positive smokers considering quitting: differences by race/ethnicity.

Authors:  Elizabeth E Lloyd-Richardson; Cassandra A Stanton; George D Papandonatos; Renée M Betancourt; Michael Stein; Karen Tashima; Kathleen Morrow; Raymond Niaura
Journal:  Am J Health Behav       Date:  2008 Jan-Feb

3.  Psychosocial correlates of HIV-monoinfection and HIV/HCV-coinfection among men who have sex with men.

Authors:  David W Pantalone; Danielle M Hessler; Sarah M Bankoff; Brijen J Shah
Journal:  J Behav Med       Date:  2011-09-23

4.  Somatic symptoms and the association between hepatitis C infection and depression in HIV-infected patients.

Authors:  Jeanie C Yoon; Paul K Crane; Paul S Ciechanowski; Robert D Harrington; Mari M Kitahata; Heidi M Crane
Journal:  AIDS Care       Date:  2011-05-23

5.  Sofosbuvir and Ribavirin for Treatment of Chronic Hepatitis C in Patients Coinfected With Hepatitis C Virus and HIV: The Impact on Patient-Reported Outcomes.

Authors:  Zobair M Younossi; Maria Stepanova; Mark Sulkowski; Susanna Naggie; Massimo Puoti; Chloe Orkin; Sharon L Hunt
Journal:  J Infect Dis       Date:  2015-01-12       Impact factor: 5.226

6.  Impact of hepatitis B and C co-infection on health-related quality of life in HIV positive individuals.

Authors:  Jennifer Gillis; Curtis Cooper; Sean Rourke; Sergio Rueda; Kelly O'Brien; Evan Collins; Anita Rachlis; Trevor A Hart; Janet Raboud
Journal:  Qual Life Res       Date:  2012-10-17       Impact factor: 4.147

7.  Predictors of active injection drug use in a cohort of patients infected with hepatitis C virus.

Authors:  Carrie Reed; Caleb Bliss; Sherri O Stuver; Timothy Heeren; Sheila Tumilty; C Robert Horsburgh; Jeffrey H Samet; Deborah J Cotton
Journal:  Am J Public Health       Date:  2012-11-15       Impact factor: 9.308

8.  Effects of liver disease on the well-being of persons living with HIV.

Authors:  Wendy A Henderson; Jane M Fall-Dickson; Elizabeth A Schlenk; Kevin H Kim; Judith T Matthews; Judith A Erlen
Journal:  J Assoc Nurses AIDS Care       Date:  2008 Sep-Oct       Impact factor: 1.354

Review 9.  Health-related quality of life assessment after antiretroviral therapy: a review of the literature.

Authors:  Harleen Gakhar; Amanda Kamali; Mark Holodniy
Journal:  Drugs       Date:  2013-05       Impact factor: 9.546

10.  Health-related quality of life in subjects with HCV/HIV coinfection: results from ACTG 5178 study.

Authors:  N Kemmer; L Hua; J W Andersen; R T Chung; A A Butt; K E Sherman
Journal:  J Viral Hepat       Date:  2012-04-22       Impact factor: 3.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.